-/-
THERMALLY REVERSIBLE POLYURETHANE HYDROGELS AND COSMETIC, BIOLOGICAL AND MEDICAL USES
Technical Field
This invention relates to thermally reversi¬ ble hydrogels and, in particular, to thermally rever¬ sible hydrogels produced from certain hydrophilic polyurethane polymers. The invention is also con¬ cerned with cosmetic, biological and medical applica- tions of the polyurethane hydrogels such as carrier and delivery systems for active agents, including 1 iving cells.
Bac σround of the Invention
U.S. Patent Nos.3,822,238 and 3,975,350 describe an active agent carrier system comprising an active agent and as a carrier vehicle therefor, a hydrophilic, preferably cross-linked polyurethane pol¬ ymer. The carrier system is utilized by subjecting it to aqueous conditions whereby the polyurethane carrier undergoes hydration and swelling with concomitant formation of an insoluble hydrogel from which the active agent is leached out by and into the aqueous medium. The rate and duration of release can be controlled by employing a carrier polymer of the req- uisite water absorptivity. Generally speaking, poly¬ urethane polymers prepared from water soluble active hydrogen resins, as exemplified by polyoxyeth lene polyols, will exhibit the highest water absorptivity. Polymers having diminished water absorptivity can be produced from less soluble resins, or by cross- linking.
The carrier system aforesaid is useful as a means for delivering various active agents, such as medicinal or cosmetic agents, to a treatment zone.
For instance, shaped articles made of the carrier system can be inserted into the body to provide preci¬ sion administering of drugs or serums over extended periods of time.
Another class of hydrophilic polyurethanes that form insoluble hydrogels in the hydrated state is disclosed in U.S. Patent Nos. 4,156,066 and 4,156,067. These polyurethanes are characerized by the presence of lactone groups in the polymer backbone. The lac- tone may be opened by hydrolytic cleavage to form carboxylic acid groups which render the polymer sol¬ uble in al kali ne medium. Other specialized hydrophil- ic polyurethanes are the polyurethane diacrylates of
U.S. Patent No. 4,359,558 and the polyurethane quater¬ nary ammonium salts of U.S. Patent No. 4,451,635.
escEi tion of the invention
An active agent carrier vehicle utilizing hydrophilic polyurethane polymers has now been discov¬ ered which differs in its composition and mode of operation from the polyurethane polymer carrier ve¬ hicles heretofore, and the provision of said polyure¬ thane polymer carrier vehicles herein and active agent carrier systems produced therefrom constitute the principal object and purpose of the invention. Other objects and purposes will become manifest in the en¬ suing description.
The active agent carrier vehicle of the invention is a thermally reversible hydrogel compri¬ sing water and a gel-forming, hydrophilic polyurethane polymer which is produced by reacting under anhydrous conditions an organic diisocyanate with a glycol com¬ ponent comprising a polyoxye thy lene glycol or mixture of glycol s in an NCO/OH weight ratio of from about 0.5/1 to about 1/1 and wherein the percentage by weight of the diisocyanate in the anhydrous reaction mixture exclusive of catalyst is from about 2% to about 25%, preferably from about 5% to about 17%.
"Anhydrous" as used in this specification means that the reaction mixture is sufficiently free of water so that the polymer product will be thermally reversible between a gel state and a sol state as further described below. Anhydrous conditions may be produced in any known manner of providing a dry reac¬ tion environment. Typical drying procedures include subjecting reactants to heat, vacuum, azeotropic dis¬ tillation or contact with dessi eating agents. Drying of the glycol component is especially important since glycols commonly contain residual moisture, often in amounts sufficient to deleteriously affect the proper- ties of the herein gel compositions. The dried gly¬ cols, which tend to be hygroscopic, should be protec¬ ted from atmospheric moisture. Other reactants, i.e., isocyanates and catalysts, can ordinarily be used without drying, owing to their lack or near lack of
associated moisture. Precautions should also be taken to ensure that all reaction vessels and apparatus are free of moisture.
It is, of course, possible that extremely small or trace amounts of moisture may still be pres¬ ent in the reaction mixture. However, by employing the usual drying techniques such as above described, it has been found that anhydrous conditions suitable for practice of the invention can be realized.
In preparing the thermally reversible hydro- gel of the invention, the polyurethane polymer compo¬ nent, preferably granulated or in small pieces, is added to an aqueous medium such as water or an aqueous solution. The resulting mixture is allowed to stand until the polymer undergoes hydration and concomitant swelling. This generally takes about one to four hours, depending on the particular polymer and its state of subdivision.
The aqueous medium containing the swollen polymer is then heated at mildly elevated temperatures with vigorous agitation. Preferably, the heating is conducted at temperatures of from about 37 °C to about
80 °C As a consequence of this treatment, the polymer is gradually assimilated into the aqueous medium. At this point, heating and stirring are discontinued. By way of analogy to the gel (or hydrogel) and sol states
of colloidal dispersions, the resulting liquid may be described as the sol state of the thermally reversible hydrogels of the invention. No necessary limitation to colloidal character is intended, however, since the sol state of the polymer in some respects appears to behave more like a true solution than a colloidal dispersion.
So far as can be ascertained, the assimila- tion of the polyurethane polymer into the aqueous medium involves both dissolution and dispersion of the polymer. As the temperature of the sol is lowered, it is believed that aggregation of the polymer particles occurs with ensuing reversion to the gel state. But whatever the mechanism of the sol/gel transition, the aqueous polyurethane polymers of the invention consti¬ tute a thermally reversible sol/hydrogel-type system.
The temperature at which the sol reverts to the gel and vice versa will depend on the particular polyurethane polymer and its concentration in the aqueous medium. Hydrogels have been obtained after equilibration in which the sol/gel transition occurs in the temperature region of about 30°C to about 45°C in general, the concentration by weight of the polymer component in the hydrogel is about 1% to about 15%, preferably about 3% to about 7%.
The polyurethane polymer used in forming the thermally reversible hydrogels of the invention is prepared by the reaction of the diisocyanate and gly¬ col component (s) in the presence of a catalyst for the polyurethane reaction. Suitable catalysts include tin salts; organic tin esters as exemplified by dibutyl tin dilaurate; tertiary amines of which triethyl di¬ amine (DABCO) and N,N,N*,N'-tetramethyl-l,3 butane diamine are representative, as well as other known catalysts for such reaction. As indicated above, to insure anhydrous conditions the glycol component is freed of moisture prior to reacting it with the diiso¬ cyanate. Drying is conveniently effected by heating the glycol component i vacuo (8 mm of Hg or less absolute) at mildly elevated temperatures, typically about 50°C to about 70°C.
In carrying out the polyurethane reaction, the moisture-free glycol component, diisocyanate and catalyst are brought together at about room tempera¬ ture or slightly higher but usually not above about 60°C. Where more than one glycol is used, these are preferably formed into a homogeneous mixture or melt before reacting with the diisocyanate. Following mixing of the glycol and diisocyanate components in the presence of the catalyst, a mildly exothermic reaction occurs, the temperature rising to about 50°C
to 80°C after which the reaction is completed by heating the mixture in the range of about 80°C to 110°C.
Representative commercial polyoxyethylene glycols are CARBCWAX0 1450, CARBOWAX* 4500 and CARBOWAX* 8000 in which the numbers refers to number average molecular weights. These products are manu¬ factured by union Carbide Corporation.
Representative diisocyanates are methyl ene- bis(cyclohexy 1-4 ,4 '-isocyanate) , trimethyl hexameth- ylene diisocyanate, isophorone diisocyanate, cyclohex- yl diisocyanate and dissocyanate precursors or equiva- lents such as the nitrile carbonates, e.g., the adipo- nitril e carbonate of the formul a:
In preparing the polyurethane polymer con¬ stituent of the herein hydrogels, the mol ecul ar weight (in the case of glycol s, hereinafter number av erage mol ecul ar weight) of the glycol component such as polyoxyethyl ene glycol must be such that the stated
diisocyanate percentage and NCO/OH mole ratio is pre¬ served in the reaction mixture. Thus, in a polyure¬ thane formulation containing by weight 10% of diiso¬ cyanate and 90% glycol and an NCO/OH mole ratio of 1/1, the glycol will have a molecular weight that is about 9 times the molecular weight of the diisocya¬ nate. If the diisocyanate aforesaid is methyl ene- bis(cycl ohexy 1-4,4 '-isocyanate) , which has a molecular weight of 260, then the molecular weight of the glycol will be 9 times 260 or 2340. Glycol molecular weights for other diisocyanate percentages and NCO/OH mole ratios are computed in like manner.
Preferably, the glycol component is a blend of a lower polyoxyethylene glycol (sometimes referred to as an "alkylene glycol") with a higher member in which the average molecular weight of the glycol blend satisfies the NCO/OH ratio and diisocyanate percen¬ tage. Thus, a glycol blend consisting of 1 mole each of CARBOWAX* 1450 and diethylene glycol M.W. 106.12 would have an average molecular weight of (1450 + 106.12/2) or 77δ * Average molecular weights for other mole ratios of glycol ε are computed similarly. Gene¬ rally, the glycol blend will contain a lower alkylene glycol such as diethylene or triethylene glycol and a higher polyoxyethylene glycol having an average molec¬ ular weight up to about 10,000. An especially pre¬ ferred glycol blend is a mixture of up to about 95% diethylene glycol and up to about 5% of one or more
polyo ye thy lene glycols having an average molecular weight in the range of from about 1450 to about 8000.
Generally speaking, high viscosities are encountered when incorporating into the aqueous medium a polyurethane polymer prepared from a polyoxyethylene glycol having a molecular weight approaching 14,000. On the other hand, a polyurethane polymer prepared from a glycol having a molecular weight below about 1450 gives hydrogels that have low viscosities. How¬ ever, blending the high molecular weight polyoxy¬ ethylene glycol with diethylene glycol as above des¬ cribed reduces the viscosity during mixing of the resulting polyurethane polymer with an aqueous medium and produces a satisfactory hydrogel. Blending di¬ ethylene glycol with a lower molecular weight poly¬ oxyethylene glycol also produces a satisfactory hydro¬ gel having good gel properties.
The thermally reversible hydrogels of the invention provide a highly effective means for the protection, controlled delivery and sustained release of an active agent. To this end, the hydrogel is melted to the liquid state and the active agent is mixed with the liquid. The temperature of the mixture is then lowered to promote gelling. The active agent is thereby encapsulated in the gel matrix and thus immobilized and protected. On melting the gel, the active material is rendered mobile in the fluidized
hydrogel for delivery and application to the treatment area at a rate dependent on its concentration in the gel, the rate at which the gel melts, and other fac¬ tors such as the environment in which melting occurs. Active agents may also be first dispersed in an aque¬ ous medium used to form the gel state of the polyure¬ thane, thereby being incorporated into the hydrogel during formation thereof.
It can thus be seen that the mechanism whereby the active agent is released from the hydrogel of the invention differs in its mode of operation as compared to leaching of the active agent from the water insoluble, water swell able polyurethane polymers of the cited patents.
Representative active agents, which can be applied singly or in combination by means of the polyurethane hydrogels of the invention, are phar a- ceuticals including anti-cancer drugs; agrichemicals including pesticides of all types such as bacterio- cides, viricides, insecticides, herbicides, larva- cides, fungicides, algaecides and nematocides; topical or dermatological agents such as deodorants, cos- metics, protective screens such as ultraviolet skin coatings, moisturizers and the like; and a host of other substances such as salts, pH regulators, hor¬ mones, enzymes and other proteinaceous substances, fragrances, deodorants, humectants, antioxidants, pre-
servatives, and food additives such as flavors, essen¬ ces and spices.
The hydrogels are also useful as non- toxic culture media for the growth of microorganisms and as gel matrices for the immobilization of enzymes, bac¬ terial cells or other microorganisms in carrying out fermentation reactions such as the manufacture of citric acid. In this specification the term "living cells" is intended to mean and include individual animal and plant cells as well as cell clusters, tissues, organs and organisms including microorganisms such as bacteria, molds and fungi. Furthermore, the hydrogels of the invention can also function as non- toxic media for electrophoretic separation of bio¬ logical substances such as enzymes, viruses, proteins and nucleic acids in accordance with well known tech¬ niques.
In the field of medicine, the hydrogels are useful in a method developed for the treatment of tumors. In this method, the thermally reversible polyurethane in gel form and containing an anti-cancer drug is applied to or at the site of a tumor. The tumor is then subjected to a source of radiant heat such as a diathermy machine. When the temperature of the tumor reaches the point at which the gel becomes fluid, the entrapped drug is released and brought into contact with the tumor. An unexpected and beneficial
result is that the combined action of the drug and the heat developed by radiation exert a synergistic ef¬ fect, thereby enhancing the therapy.
In cosmetic applications, such as in the preparation of face masks, wrinkle creams, mascara bases, dry-skin protectants, and the like, the hydro¬ gels are substituted for or used in addition to the gelatinous substances commonly present in such formu- lations.
The following non-limiting examples will further illustrate the invention. In the examples, all parts are by weight unless specified otherwise.
EXAMPLE 1 - CELL CϋLTϋRING
A polyether moiety is prepared by mixing 81.4 parts of CARBOWAX# 4500 polyoxyethylene glycol
(union Carbide Corporation) and 4.1 parts of diethy¬ lene glycol with stirring at 70 °C to form a homogene¬ ous melt. The resulting glycol mixture is then sub¬ jected to vacuum in order to remove moisture. While continuing the stirring, 14.5 parts of DESMODUR W* diisocyanate [ (methyl enebis (cycl ohexy 1-4 ,4 '-isocya¬ nate), Mobay Chemical Corp.] are added. When the tem¬ perature decreases to 50°C, 0.1 part of T^2 catalyst (dibutyl tin dilaurate. Air Products and Chemicals,
Inc.) is added and the mixture all owed to exotherm to about 70°C. The reaction mass is then poured into a polypropyl ene pan. During pouring, the temperature of the mass continues to rise and, as the temperature approaches 80 ° C, the mass foams. Upon compl etion of the pouring operation, the pan is pl aced in an air circulating oven at 100 ° C and maintained in the oven for one hour to cure the polymer.
After cooling to ambient room temperature, the polymer mass i s cut i nto smal l pi eces. A suf f i¬ cient amount of the small pieces is mixed with water to form a mixture containing 12% sol ids. The mixture is stirred whil e increasing the temperature of the mixture to 95 °C With continued stirring, the mass begins to homogeniz e and then thickens. Upon cooling to 55 °C, the mass sets into a highly viscous gel. If desired, l ower solids concentration hydrogel s may be formed by dil ution with water or with an aqueous culture medium. For storage purposes, the hydrogel may be dri ed.
Hydrogel s of any desired sol ids content and of any desired aqueous consistency may be prepared by mixing the required amount of the dry polymer with water and/or an aqueous medium such as a culture medium, and heating the mixture to about 40 °C with stirring. A hydrogel containing 5% of the above- described polymer with an aqueous culture medium is in
its sol state, i.e., a flowable, somewhat syrupy liq¬ uid at 37 °C But when cooled to room temperature (20°C - 22°C), the mixture sets into a solid gel and thus can be used as an agar substitute for the cultur- ing of cells and organisms. The liquid hydrogel may be brought to the desired pH for specific cells or microorganisms (such as ~. coli) by the addition of a buffer solution or a dilute acid or alkaline solution.
EXAMPLE 2 - TUMOR TREATMENT
To 81.4 parts of CARBOWAX* 4500 polyethylene glycol having a number average molecular weight of 4500 is added with mixing 4.1 parts of diethylene glycol. The mixture is heated to 60°C to 65°C to form a homogeneous melt which is placed under vacuum until all traces of moisture are removed.
While stirring, 14.5 parts of DESMODUR W# diisocyanate are added to the mixture. The tempera¬ ture of the mixture drops. When it reaches about 50°C, 0.2 part of T12 catalyst is added. The mixture then starts to exotherm. When the temperature reaches 73°C to 75°C, the mixture is poured into a polypropy¬ lene tray, the tray is placed in a circulating oven and the polymer cured at 100 °C for one hour. The resulting compact slab or polymer is cut into small pieces, using a granulator.
Bleomycin sulfate (an anti-cancer drug) is dissolved in physiological saline at 100 ppm concen¬ tration. The granulated polymer is placed in the saline with the drug, 7 parts polymer per 93 parts of the saline, and the polymer allowed to swell for three hours.
After this period, the temperature of the polymer- saline system is slowly raised to 75°C to 76°C under vigorous stirring. The polymer dissolves and forms a homogeneous solution. The solution is slowly cooled under constant stirring to 35 °C to 36 °C, when the stirring is discontinued and the mixture allowed to gel.
The gel remains solid at temperatures up to 37°C to 38°C, even in water or physiological saline, and releases the entrapped drug only slowly. When heated to 45°C, the gel melts and releases the en- trapped drug rapidly. Thus, it is suitable as a carrier for anti-cancer and other drugs, which can be placed at the tumor site or a site of infection and released during hyperthermia; that is, when the site is overheated to 45 °C
EXAMPLE 3 - COSMETIC DSES
In a suitable vessel, 32.0 parts of CARB0WAX# 1450, 52.7 parts of CARB0WAX# 8000, and 2.5 parts of diethylene glycol are mixed and heated to
65°C Vacuum is applied to the heated mixture until all traces of moisture are removed.
To the heated mixture is added 12.7 parts of DESMODϋR W#. When the temperature falls to 45 °C to
48°C, 0.15 part of Tj catalyst is added under con¬ stant stirring. The mixture starts to exotherm. When the temperature reaches 70°C, stirring is discontinued and the mixture poured into a polypropylene tray. The tray is placed in a circulating oven and the mixture cured for one hour at 100°C
The solid block of polymer is granulated to 1/ 4-inch particles. A gel is prepared therefrom con- taining 25% solids, following the procedure of Example
1. The solvent in this case is 85 parts of distilled water and 15 parts of SDA ethyl alcohol. The gel has a viscosity of 1,200 cP at 25°C, and is used for preparation of face masks, wrinkle creams and as a base for mascara.
EXAMPLE 4 - SKIN PROTECTANT
In a suitable vessel, 79.3 parts of CARBOWAX* 8000 and 5.4 parts of diethylene glycol are melted together at 65°C and vacuum is applied to remove moisture. 15.3 parts of DESMODUR W# and 0.2 part of catalyst T12 are then added. The mixture exotherms and is poured into a polypropylene tray. The tray is placed in a circulating oven and the mixture cured at 90 °C for 1.5 hours. The resulting polymer is then granulated into 1/4-inch size pellets.
A gel is prepared from 5 parts of the poly¬ mer and 95 parts of water, following the procedure described in Example 1. The gel is easily spreadable on the skin, where it forms an invisible, nongreasy and nontacky film, usable as skin protection for dry skin, psoriasis, etc. The film is easily removed with warm water.